Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Iptacopan hydrochloride (LNP023 hydrochloride) 是一种可口服、高效和高选择性的因子 B 抑制剂,IC50 为 10 nM。 LNP023 显示与人因子 B 的直接、可逆和高亲和力结合,KD 为 7.9 nM。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 1,180 | 现货 | ||
5 mg | ¥ 2,660 | 现货 | ||
10 mg | ¥ 4,320 | 现货 | ||
25 mg | ¥ 6,730 | 现货 | ||
50 mg | ¥ 8,900 | 现货 | ||
100 mg | ¥ 12,200 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 2,920 | 现货 |
产品描述 | Iptacopan hydrochloride (LNP023 hydrochloride) is an orally bioavailable, highly potent and highly selective factor B inhibitor with an IC50 of 10 nM. Iptacopan hydrochloride shows direct, reversible, and high-affinity binding to human factor B with a KD of 7.9 nM. |
靶点活性 | FB:10 nM, FB:7.9 nM(KD) |
体外活性 | LNP023 demonstrates excellent selectivity over other proteases affording IC50 values of >30 μM across a panel of 41 human proteases, including the AP protein factor D (>100 μM)[3]. |
体内活性 |
LNP023 (20-180 mg/kg; oral administration) is effective upon prophylactic and therapeutic dosing in an experimental model of membranous nephropathy in rats and prevents KRN (150 μL)-induced arthritis in mice[2]. After oral administration (rat 30 and, dog 10 mg/kg), LNP023 exhibits moderate half-lives (T1/2; Wistar Han rats 3.4 h, beagle dogs 5.5 h) and Cmax (Wistar Han rats 410 nM, beagle dogs 2200 nM)[3]. |
别名 | Iptacopan HCl, LNP023 hydrochloride |
分子量 | 458.98 |
分子式 | C25H31ClN2O4 |
CAS No. | 1646321-63-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: 50 mg/mL (108.94 mM), Sonication and heating are recommended.
DMSO: 250 mg/mL (544.69 mM), Sonication is recommended.
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
H2O / DMSO | 1 mM | 2.1787 mL | 10.8937 mL | 21.7874 mL | 54.4686 mL |
5 mM | 0.4357 mL | 2.1787 mL | 4.3575 mL | 10.8937 mL | |
10 mM | 0.2179 mL | 1.0894 mL | 2.1787 mL | 5.4469 mL | |
20 mM | 0.1089 mL | 0.5447 mL | 1.0894 mL | 2.7234 mL | |
50 mM | 0.0436 mL | 0.2179 mL | 0.4357 mL | 1.0894 mL | |
100 mM | 0.0218 mL | 0.1089 mL | 0.2179 mL | 0.5447 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Iptacopan hydrochloride 1646321-63-2 Immunology/Inflammation Complement System Iptacopan HCl LNP023 hydrochloride LNP 023 hemoglobinuria inhibit PNH atypical pathogenesis Inhibitor LNP023 factor B system LNP 023 Hydrochloride Iptacopan complement paroxysmal syndrome LNP-023 pathway LNP-023 Hydrochloride hemolytic uremic alternative LNP023 Hydrochloride nocturnal Iptacopan Hydrochloride inhibitor